PERITECH PHARMA

Peritech pharma is a specialty pharmaceuticals development company focusing on the anal-rectal area, targeting numerous indications with large markets and clear unmet medical needs. Peritech Pharma is led by a team of seasoned professionals with over 50 years of combined experience in founding and managing startup companies in the life sciences space, and including physicians, formulation developers, regulatory and IP experts as well as business professionals. In June 2014 Peritech completed a clinical study comparing its lead OTC product (PP-110 for hemorrhoids) to a global leader in the field, with excellent results. The company is currently seeking partners for marketing this product.